Cornelia Bargmann will step down from drugmaker AstraZeneca’s board next month to serve as president of Chan Zuckerberg Science.
Mr. Zuckerberg and Dr. Chan presented their new $3 billion initiative last week, with the goal of accelerating scientific research to cure infectious diseases by the end of the century.
Their plan follows suit with the health ambitions of the Bill & Melinda Gates Foundation, a philanthropic effort funded out of the tech industry that has also recruited pharmaceutical leaders in the past for staff, according to Fortune.
More articles on executive moves:
Howard University Hospital appoints James Diegel CEO
Eastern Maine Healthcare Systems names Timothy Dentry COO: 3 things to know
Sentry Data Systems names Tom Tran CFO, COO